• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Introduction to 1-Methyl-4-Nitro-Indazole (CAS No. 26120-43-4)

1-Methyl-4-nitro-indazole, with the CAS number 26120-43-4, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the indazole class, which is known for its diverse biological activities and potential therapeutic applications. The structure of 1-methyl-4-nitro-indazole consists of a five-membered indazole ring with a methyl group at the 1-position and a nitro group at the 4-position, contributing to its unique chemical and biological properties.

The synthesis of 1-methyl-4-nitro-indazole has been extensively studied, and various methods have been reported in the literature. One common approach involves the reaction of 1-methylindazole with nitric acid or other nitration agents. The resulting compound is highly stable and can be easily purified, making it suitable for further chemical modifications and biological evaluations. Recent advancements in synthetic methodologies have also focused on improving the yield and selectivity of the nitration process, thereby enhancing the overall efficiency of 1-methyl-4-nitro-indazole production.

In terms of its biological activities, 1-methyl-4-nitro-indazole has shown promising results in several areas. One of the most notable applications is its potential as an anti-inflammatory agent. Studies have demonstrated that this compound can effectively inhibit the production of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), in both in vitro and in vivo models. This property makes it a valuable candidate for the development of new anti-inflammatory drugs, particularly for conditions such as rheumatoid arthritis and inflammatory bowel disease.

Beyond its anti-inflammatory properties, 1-methyl-4-nitro-indazole has also been investigated for its anticancer potential. Research has shown that this compound can induce apoptosis in various cancer cell lines, including those derived from breast, lung, and colon cancers. The mechanism of action involves the modulation of key signaling pathways, such as the PI3K/Akt and MAPK pathways, which are often dysregulated in cancer cells. These findings suggest that 1-methyl-4-nitro-indazole could be a promising lead compound for the development of novel anticancer therapies.

The pharmacokinetic properties of 1-methyl-4-nitro-indazole have also been studied to assess its suitability as a drug candidate. Preclinical studies have demonstrated that this compound exhibits good oral bioavailability and a favorable pharmacokinetic profile, with a reasonable half-life and low toxicity. These characteristics are crucial for ensuring that the compound can be effectively delivered to target tissues and maintain therapeutic concentrations over an extended period.

In addition to its direct therapeutic applications, 1-methyl-4-nitro-indazole has been used as a building block for the synthesis of more complex molecules with enhanced biological activities. For example, researchers have explored the synthesis of derivatives by introducing additional functional groups or modifying existing substituents on the indazole ring. These derivatives have shown improved potency and selectivity in various biological assays, further expanding the potential applications of this core structure.

The safety profile of 1-methyl-4-nitro-indazole_{^{(CAS No. 26120-43-4)}) has been evaluated through extensive toxicological studies. These studies have generally shown that the compound is well-tolerated at therapeutic doses, with no significant adverse effects observed in animal models. However, as with any new chemical entity, further clinical trials are necessary to fully assess its safety and efficacy in human subjects.}.

In conclusion, 1-methyl-4-nitro-indazole (CAS No. 26120-43-4) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure, coupled with its diverse biological activities, makes it an attractive candidate for further development into novel therapeutic agents. Ongoing research continues to uncover new insights into its mechanisms of action and potential uses, contributing to advancements in drug discovery and development.

• 830320-66-6(1H-Indazol-4-amine, 6-nitro-1-phenyl-)
• 6850-22-2(2-Methyl-6-nitro-2H-indazole)
• 58706-36-8(1-methyl-7-nitro-indazole)
• 5228-48-8(2-methyl-5-nitro-indazole)
• 5228-49-9(1-methyl-5-nitro-indazole)
• 6850-23-3(1-methyl-6-nitro-indazole)
• 91178-59-5(6-Nitro-1-phenyl-1H-indazole)
• 26120-44-5(2-methyl-4-nitro-indazole)
• 62642-77-7(1H-Indazole, 1-ethenyl-6-nitro-)
• 61063-14-7(2H-Indazole, 6-nitro-2-phenyl-)